Health In Tech, Inc.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Stuart, State of Florida, on March 17, 2025.
| HEALTH IN TECH, INC. | |
| By: | /s/ Tim Johnson |
| Name: | Tim Johnson |
| Title: | Chief Executive Officer and Chairman |
Pursuant to the requirements of the Securities Exchange Act of 1934, report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Tim Johnson | Chairman and Chief Executive Officer and Director | March 17, 2025 |
| Tim Johnson | (Principal Executive Officer) | |
| /s/ LinLin Qian | Chief Financial Officer and Director | March 17, 2025 |
| LinLin Qian | (Principal Financial and Accounting Officer) | |
| /s/ William D. Howard | Director | March 17, 2025 |
| William D. Howard | ||
| /s/ Chike Umemezia | Director | March 17, 2025 |
| Chike Umemezia | ||
| /s/ Lynn Liang | Director | March 17, 2025 |
| Lynn Liang | ||
| /s/ Timothy Hayes | Director | March 17, 2025 |
| Timothy Hayes | ||
**Health In Tech, Inc. and Subsidiaries
Index to Consolidated Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 206) | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations for the years ended December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Equity for the years ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 | F-6 |
| Notes to the Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.